Osmotica Pharmaceutical is a fully-integrated pharmaceutical company specializing in osmotic drug delivery. The Company possesses a diversified product portfolio in the specialty neurology and women's health space, including five promoted products and approximately 35 non-promoted products, several of which incorporate the proprietary Osmodex® drug delivery system. The non-promoted product portfolio includes methylphenidate HCl ER tablets and venlafaxine HCl ER tablets and prescription and non-prescription dietary supplements.
Gross profit (Q3, 2019)
Gross profit margin (Q3, 2019), %
Net income (Q3, 2019)
EBIT (Q3, 2019)
Market capitalization (21-Feb-2020)
Closing stock price (21-Feb-2020)
Osmotica Pharmaceuticals revenue breakdown by business segment: 9.4% from Lorzone, 7.8% from Divigel, 40.4% from Venlafaxine ER, 18.4% from Methylphenidate and 24.0% from Other
When was Osmotica Pharmaceuticals founded?
Osmotica Pharmaceuticals was founded in 2000.
Who are Osmotica Pharmaceuticals key executives?
Osmotica Pharmaceuticals's key executives are David Burgstahler and Sriram Venkataraman.
How many employees does Osmotica Pharmaceuticals have?
Osmotica Pharmaceuticals has 466 employees.
What is Osmotica Pharmaceuticals revenue?
Latest Osmotica Pharmaceuticals annual revenue is $263.7 m.
What is Osmotica Pharmaceuticals revenue per employee?
Latest Osmotica Pharmaceuticals revenue per employee is $565.9 k.
Who are Osmotica Pharmaceuticals competitors?
Competitors of Osmotica Pharmaceuticals include Horizon Therapeutics, Esperion Therapeutics and Vitality Biopharma.
Where is Osmotica Pharmaceuticals headquarters?
Osmotica Pharmaceuticals headquarters is located at 400 Crossing Blvd, Bridgewater.
Where are Osmotica Pharmaceuticals offices?
Osmotica Pharmaceuticals has offices in Bridgewater, Marietta, Sayreville, Tampa and in 4 other locations.
How many offices does Osmotica Pharmaceuticals have?
Osmotica Pharmaceuticals has 8 offices.
Receive alerts for 300+ data fields across thousands of companies